Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
183490.KQ Stock Summary
Top 10 Correlated ETFs
183490.KQ
In the News
183490.KQ Financial details
Company Rating
Neutral
Market Cap
169.28B
Income
-9.33B
Revenue
76.04B
Book val./share
2274.9
Cash/share
1613.18
Dividend
-
Dividend %
-
Employees
113
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-8.08
Forward P/E
-
PEG
1.23
P/S
3.26
P/B
0.75
P/C
1.16
P/FCF
-9.14
Quick Ratio
14.47
Current Ratio
16.04
Debt / Equity
0.03
LT Debt / Equity
0.01
-
-
EPS (TTM)
-109.82
EPS next Y
-
EPS next Q
-
EPS this Y
-65.51%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-17.33%
Revenue last 5Y
19.3%
Revenue Q/Q
17.43%
EPS Q/Q
-30.45%
-
-
-
-
SMA20
16.08%
SMA50
10.62%
SMA100
59.17%
Inst Own
-
Inst Trans
-
ROA
-9%
ROE
-9%
ROC
-0.07%
Gross Margin
8%
Oper. Margin
-30%
Profit Margin
-40%
Payout
-
Shs Outstand
85.07M
Shs Float
69.97M
-
-
-
-
Target Price
-
52W Range
1110.0-2290.0
52W High
-17.99%
52W Low
+69.19%
RSI
58.49
Rel Volume
1.23
Avg Volume
278.78K
Volume
342.85K
Perf Week
-0.21%
Perf Month
7.5%
Perf Quarter
30.96%
Perf Half Y
29.25%
-
-
-
-
Beta
1.449
-
-
Volatility
57.74%, 137.43%
Prev Close
-0.21%
Price
1878
Change
-4.96%
183490.KQ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 530.05 | 420.05 | 460.48 | 337.96 | 895.32 | |
Net income per share | -284.31 | -284.83 | -558.47 | -318.36 | -109.81 | |
Operating cash flow per share | -254.26 | -228.11 | -372.56 | -181.68 | -120.78 | |
Free cash flow per share | -302.13 | -278.49 | -490.46 | -283.34 | -147.89 | |
Cash per share | 765.06 | 1.47K | 1.9K | 2.45K | 1.62K | |
Book value per share | 1.25K | 1.18K | 1.5K | 2.56K | 2.28K | |
Tangible book value per share | 1.22K | 1.15K | 1.37K | 2.53K | 2.27K | |
Share holders equity per share | 1.25K | 1.18K | 1.5K | 2.56K | 2.28K | |
Interest debt per share | 49.69 | 719.36 | 1.23K | 600.1 | 67.03 | |
Market cap | 2701.31B | 2796.65B | 2270.2B | 131.63B | 153.04B | |
Enterprise value | 2702.12B | 2837.86B | 2319.4B | 161.73B | 143.23B | |
P/E ratio | -160.04 | -159.75 | -81.47 | -5.25 | -16.41 | |
Price to sales ratio | 85.84 | 108.32 | 98.81 | 4.94 | 2.01 | |
POCF ratio | -178.95 | -199.46 | -122.13 | -9.19 | -14.92 | |
PFCF ratio | -150.6 | -163.38 | -92.77 | -5.89 | -12.18 | |
P/B Ratio | 36.48 | 38.58 | 30.41 | 0.65 | 0.79 | |
PTB ratio | 36.48 | 38.58 | 30.41 | 0.65 | 0.79 | |
EV to sales | 85.87 | 109.92 | 100.95 | 6.07 | 1.88 | |
Enterprise value over EBITDA | -186.92 | -179.68 | -124.41 | -13.03 | -12.76 | |
EV to operating cash flow | -179 | -202.4 | -124.77 | -11.29 | -13.96 | |
EV to free cash flow | -150.64 | -165.79 | -94.78 | -7.24 | -11.4 | |
Earnings yield | -0.01 | -0.01 | -0.01 | -0.19 | -0.06 | |
Free cash flow yield | -0.01 | -0.01 | -0.01 | -0.17 | -0.08 | |
Debt to equity | 0.04 | 0.59 | 0.69 | 0.18 | 0.03 | |
Debt to assets | 0.03 | 0.35 | 0.39 | 0.15 | 0.02 | |
Net debt to EBITDA | -0.06 | -2.61 | -2.64 | -2.42 | 0.87 | |
Current ratio | 8.43 | 10.73 | 2.05 | 5.21 | 12.33 | |
Interest coverage | -103.64 | -12.16 | -2.18 | -1.48 | -23.76 | |
Income quality | 0.89 | 0.8 | 0.67 | 0.57 | 1.1 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.16 | 0.21 | 0.35 | 0.26 | 0 | |
Research and developement to revenue | 0.36 | 0.5 | 0.41 | 0.25 | 0.07 | |
Intangibles to total assets | 0.02 | 0.02 | 0.05 | 0.01 | 0.01 | |
Capex to operating cash flow | 0.19 | 0.22 | 0.32 | 0.56 | 0.22 | |
Capex to revenue | -0.09 | -0.12 | -0.26 | -0.3 | -0.03 | |
Capex to depreciation | -1.46 | -1.52 | -2.79 | -3.35 | -0.66 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.82K | 2.75K | 4.34K | 4.28K | 2.37K | |
ROIC | -0.22 | -0.14 | -0.15 | -0.06 | -0.07 | |
Return on tangible assets | -0.2 | -0.14 | -0.22 | -0.1 | -0.04 | |
Graham Net | 767.04 | 771 | 900.35 | 2.03K | 1.69K | |
Working capital | 55.74B | 95.21B | 56.16B | 178.03B | 160.32B | |
Tangible asset value | 72.48B | 70.51B | 68.19B | 199.56B | 193.15B | |
Net current asset value | 52.29B | 53.68B | 51.36B | 174.5B | 157.56B | |
Invested capital | 0.04 | 0.59 | 0.69 | 0.18 | 0.03 | |
Average receivables | 8.55B | 7.1B | 5.39B | 8.31B | 15.94B | |
Average payables | 1.86B | 1.8B | 1.56B | 1.87B | 3.99B | |
Average inventory | 7.49B | 8.51B | 8.77B | 9.07B | 12.37B | |
Days sales outstanding | 110.5 | 66.12 | 97.02 | 144.01 | 102.54 | |
Days payables outstanding | 34.05 | 12.93 | 35.17 | 21.83 | 32.58 | |
Days of inventory on hand | 97.6 | 136.76 | 130.59 | 142.89 | 74.99 | |
Receivables turnover | 3.3 | 5.52 | 3.76 | 2.53 | 3.56 | |
Payables turnover | 10.72 | 28.23 | 10.38 | 16.72 | 11.2 | |
Inventory turnover | 3.74 | 2.67 | 2.79 | 2.55 | 4.87 | |
ROE | -0.23 | -0.24 | -0.37 | -0.12 | -0.05 | |
Capex per share | -47.87 | -50.38 | -117.9 | -101.66 | -27.11 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 78.87 | 184.98 | 204.88 | 232.36 | 272.86 | |
Net income per share | -102.73 | -28.46 | -28.85 | -30.97 | -21.54 | |
Operating cash flow per share | -48.29 | -21.1 | -45.55 | -30.13 | -23.95 | |
Free cash flow per share | -69.2 | -30.3 | -46.83 | -40.38 | -30.34 | |
Cash per share | 2.29K | 1.89K | 1.78K | 1.71K | 1.61K | |
Book value per share | 2.39K | 2.36K | 2.32K | 2.28K | 2.27K | |
Tangible book value per share | 2.37K | 2.29K | 2.26K | 2.21K | 2.27K | |
Share holders equity per share | 2.39K | 2.36K | 2.32K | 2.28K | 2.27K | |
Interest debt per share | 456.22 | 111.66 | 67.22 | 64.85 | 60.46 | |
Market cap | 140.76B | 161.84B | 157.8B | 128.02B | 153.29B | |
Enterprise value | 170.86B | 167.99B | 155.88B | 129.44B | 143.47B | |
P/E ratio | -4.06 | -16.82 | -16.07 | -12.15 | -20.91 | |
Price to sales ratio | 21.18 | 10.35 | 9.05 | 6.48 | 6.6 | |
POCF ratio | -34.58 | -90.78 | -40.73 | -49.95 | -75.23 | |
PFCF ratio | -24.13 | -63.21 | -39.61 | -37.27 | -59.4 | |
P/B Ratio | 0.7 | 0.81 | 0.8 | 0.66 | 0.79 | |
PTB ratio | 0.7 | 0.81 | 0.8 | 0.66 | 0.79 | |
EV to sales | 25.7 | 10.75 | 8.94 | 6.55 | 6.18 | |
Enterprise value over EBITDA | -58.22 | -75.38 | -54.26 | -38.81 | -51.49 | |
EV to operating cash flow | -41.98 | -94.23 | -40.23 | -50.5 | -70.41 | |
EV to free cash flow | -29.29 | -65.61 | -39.13 | -37.68 | -55.6 | |
Earnings yield | -0.06 | -0.01 | -0.02 | -0.02 | -0.01 | |
Free cash flow yield | -0.04 | -0.02 | -0.03 | -0.03 | -0.02 | |
Debt to equity | 0.18 | 0.05 | 0.03 | 0.03 | 0.03 | |
Debt to assets | 0.15 | 0.04 | 0.03 | 0.03 | 0.02 | |
Net debt to EBITDA | -10.26 | -2.76 | 0.67 | -0.43 | 3.52 | |
Current ratio | 5.21 | 11.32 | 16.04 | 11.7 | 12.33 | |
Interest coverage | -3.03 | -7.46 | -50.56 | -65.81 | -51.24 | |
Income quality | 0.47 | 0.74 | 1.58 | 0.97 | 1.11 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.3 | 0.13 | 0.13 | 0 | 0 | |
Research and developement to revenue | 0.21 | 0.11 | 0.08 | 0.05 | 0.06 | |
Intangibles to total assets | 0.01 | 0.03 | 0.03 | 0.03 | 0.01 | |
Capex to operating cash flow | 0.43 | 0.44 | 0.03 | 0.34 | 0.27 | |
Capex to revenue | -0.27 | -0.05 | -0.01 | -0.04 | -0.02 | |
Capex to depreciation | -2.71 | -0.94 | -0.11 | -0.96 | -0.66 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.35K | 1.23K | 1.23K | 1.26K | 1.05K | |
ROIC | -0.02 | -0.01 | -0.02 | -0.02 | -0.01 | |
Return on tangible assets | -0.04 | -0.01 | -0.01 | -0.01 | -0.01 | |
Graham Net | 1.9K | 1.81K | 1.77K | 1.71K | 1.69K | |
Working capital | 178.03B | 167.96B | 166.5B | 164.03B | 160.32B | |
Tangible asset value | 199.56B | 193.52B | 192.04B | 188.06B | 193.15B | |
Net current asset value | 174.5B | 164.35B | 161.35B | 158.55B | 157.56B | |
Invested capital | 0.18 | 0.05 | 0.03 | 0.03 | 0.03 | |
Average receivables | 9B | 10.06B | 10.46B | 14.9B | 19.92B | |
Average payables | 1.94B | 2.43B | 3.16B | 4.97B | 6.75B | |
Average inventory | 9.86B | 11.21B | 13.19B | 14.09B | 14.67B | |
Days sales outstanding | 142.3 | 55.27 | 58.5 | 84.1 | 82.83 | |
Days payables outstanding | 22.64 | 20.94 | 15.77 | 32.72 | 26.29 | |
Days of inventory on hand | 148.24 | 78.37 | 73.85 | 67.34 | 60.52 | |
Receivables turnover | 0.63 | 1.63 | 1.54 | 1.07 | 1.09 | |
Payables turnover | 3.97 | 4.3 | 5.71 | 2.75 | 3.42 | |
Inventory turnover | 0.61 | 1.15 | 1.22 | 1.34 | 1.49 | |
ROE | -0.04 | -0.01 | -0.01 | -0.01 | -0.01 | |
Capex per share | -20.91 | -9.2 | -1.29 | -10.25 | -6.38 |
183490.KQ Frequently Asked Questions
What is Enzychem Lifesciences Corporation stock symbol ?
Enzychem Lifesciences Corporation is a KR stock and trading under the symbol 183490.KQ
What is Enzychem Lifesciences Corporation stock quote today ?
Enzychem Lifesciences Corporation stock price is $1878 today.
Is Enzychem Lifesciences Corporation stock public?
Yes, Enzychem Lifesciences Corporation is a publicly traded company.